New appropriate use criteria guide treatment of patients with heart blockage

January 06, 2009

Practical tool aids physicians, patients, payers

If you're committed to fitness, the decision to climb a couple of flights of stairs rather than take the elevator is clear. But if you develop chest pain on the way up, deciding how to treat the symptoms of clogged arteries in your heart is much more complicated.

Whether it's appropriate to treat chest pain with medical therapy alone or prescribe medical therapy and also perform revascularization-that is, by restoring good blood flow to the heart muscle with a balloon-tipped catheter or bypass surgery-depends on several factors that vary from patient to patient. In some cases the decision is obvious; in others, it's more nuanced.

Now physicians, patients and health insurers have a practical tool for weighing each of those factors and arriving at the right treatment decision. The new document, titled "Appropriate Use Criteria for Coronary Revascularization," appears in the February 10, 2009, issue of the Journal of the American College of Cardiology (JACC) and online at www.acc.org. The document will also be published in the January 5, 2009, online issues of Catheterization and Cardiovascular Interventions (CCI) and Circulation: Journal of the American Heart Association, and online at www.scai.org.

"One of the strengths of this document is that it provides a framework for thinking about clinical scenarios and having a discussion about coronary revascularization," said Manesh R. Patel, M.D., chair of the appropriate use criteria writing group and an assistant professor of medicine at Duke University and the Duke Clinical Research Institute in Durham, NC. "These recommendations describe when coronary revascularization would be expected to improve a patient's health status."

The new appropriate use criteria are the first to focus on cardiac treatment, rather than on diagnostic testing. They were jointly developed by the American College of Cardiology, Society for Cardiovascular Angiography and Interventions, Society of Thoracic Surgeons, American Association for Thoracic Surgery, American Heart Association, and American Society of Nuclear Cardiology. They have been endorsed by the American Society of Echocardiography, Heart Failure Society of America, and Society of Cardiovascular Computed Tomography.

Appropriate use criteria differ from clinical guidelines both in their purpose and their format. While guidelines provide a comprehensive summary of evidence from clinical trials, appropriate use criteria focus on the types of patients cardiologists see in the clinic and hospital every day. Clinical studies may not have included such patients and, therefore, scientific evidence may not be readily available. Appropriate use criteria also present information in easily understood clinical scenarios that characterize patients according to four critical features:

* The severity and type of symptoms;
* How much cholesterol plaque has built up and in which arteries;
* How much of the heart muscle, according to stress testing, is being starved for blood and oxygen (a condition known as ischemia); and
* Whether the patient is already taking the right heart medications in the right dosages.

In developing the appropriate use criteria, a 17-member technical panel made up of general cardiologists, interventional cardiologists, cardiac surgeons, internal medicine specialists, health services researchers and others sifted through approximately 180 clinical scenarios, scoring each according to whether revascularization was appropriate, inappropriate or uncertain.

"This was quite a serious undertaking," said Peter K. Smith, M.D., a cardiac surgeon member of the writing committee on behalf of The Society of Thoracic Surgeons. "The process involved extensive review and debate of the available body of evidence, and resulted in remarkable consensus between specialties." Dr. Smith is also professor and chief of cardiothoracic surgery at Duke University.

Revascularization was considered appropriate if the expected improvements in survival, symptoms, functional status and/or quality of life outweighed the possible risks. In most cases, the panel considered revascularization as either bypass surgery or a catheter procedure (also known as percutaneous coronary intervention, or PCI). Because evidence is available to support either procedure for patients with advanced coronary disease, each method of revascularization was independently rated.

The panel determined that revascularization would be inappropriate in a patient who had plaque build-up in one or two arteries, experienced symptoms only during heavy exercise, had a small amount of heart muscle at risk, and was not taking medication to help control symptoms. However, they deemed revascularization appropriate if a similar patient had severe symptoms despite already taking the best available heart medication.

Appropriate use criteria are not intended to diminish the importance of clinical judgment in evaluating individual patients, nor to include every possible type of patient. Instead, one of their most important uses will be in evaluating patterns of care, and in helping to reduce the large variation in rates of revascularization that has been observed throughout the country.

"For physicians who look at the appropriate use criteria and conclude that 95 to 100 percent of the revascularization procedures they perform would be graded as appropriate-terrific," said Gregory J. Dehmer, M.D., a writing committee member and past president of the Society for Cardiovascular Angiography and Interventions. "But for those who find that only 60 or 70 percent of their procedures are appropriate and the rest are inappropriate, this document provides a very powerful message and gives them a benchmark for improving their practice." Dr. Dehmer is also a professor of medicine at Texas A & M University College of Medicine and cardiology director at Scott & White Clinic, both in Temple, TX.

It is also hoped that health insurers will use the appropriate use criteria in developing consistent payment and preauthorization policies and in conducting quality reviews.

"In the arena of cardiovascular science, we have a fair amount of data on revascularization and its ability to improve how patients feel or long they live," Dr. Patel said. "As a group that includes general cardiologists, interventionalists and surgeons, we're saying: For these common clinical scenarios, here is when it's appropriate-in most patients-to perform revascularization."

American College of Cardiology

---

---

	Cerebral Revascularization: Techniques in Extracranial-to-Intracranial Bypass Surgery: Expert Consult - Online and Print, 1e by Saleem I. Abdulrauf MD FACS (Author) Cerebral Revascularization: Techniques in Extracranial-to-Intracranial Bypass Surgery, by Saleem I. Abdulrauf, MD, FACS, offers unmatched expert guidance. Through a series of dynamic, step-by-step instructional videos of the most common and uncommon procedures, you will deepen your understanding of these techniques and be able to confidently perform them. Edited and written by international leaders in neurosurgery, this definitive reference - with a foreword written by M. Gazi Yasargil, MD creator of the procedure - is the first and only text entirely dedicated to this surgery and provides you with exclusive, authoritative information. Access the full text, video library, and reference links to PubMed at www.expertconsult.com.Sharpen your skills in Extracranial-to-Intracranial (EC-IC)...
	CORONARY REVASCULARIZATION IN MULTIVESSEL DISEASE: Which is better, stents or surgery? Findings to date on important, practical differences between percutaneous ... bypass grafting. (Postgraduate Medicine) by JTE Multimedia Coronary artery disease (CAD) remains the major cardiovascular health issue in contemporary clinical practice. Treatment options for multivessel CAD include medical therapy, percutaneous coronary intervention (PCI), and coronary artery bypass grafting (CABG). Here, the authors review the most recent data that compare intracoronary stenting to CABG in multivessel disease. They address therapeutic issues surrounding proper selection of the optimal revascularization strategy and give special consideration to high-risk populations, such as patients with diabetes. Original Publication Date: December 2005
	Direct Myocardial Revascularization: History, Methodology, Technology by Peter Whittaker (Editor), George S. Abela (Editor) The last five years have witnessed an increasing interest in the subject of transmyocardial revascularization (TMR). The ideas and concepts associated with this particular method of myocardial revascularization have changed dramatically over a short period of time. The original premise of `de-evolving' mammalian hearts to recreate a reptilian-like myocardial circulation by multiple channels through the myocardium has been almost completely dismissed. Now, the most popular notion is that there is an angiogenic response to myocardial channel making. It is this development of new blood vessels that is thought to be responsible for the apparent improvements in symptoms and blood flow. Along the way, the idea that a channel could stay open and allow blood to flow directly from the...
	Cerebral Revascularization: Microsurgical and Endovascular Techniques by Eric Nussbaum (Editor), J Mocco (Editor) State-of-the-art brain revascularization techniques in a vividly illustrated how-to guideIn Cerebral Revascularization: Microsurgical and Endovascular Techniques, renowned surgical experts combine their expertise to provide the most current and comprehensive coverage of open brain bypass and endovascular options currently available.A detailed introduction familiarizes readers with the various indications for these technically demanding procedures. Concise chapters then supply thorough coverage of surgical strategies, complications, and outcomes using case examples from the authors' own collections to help prepare readers for surgery. Enhancing the text throughout, operative photographs and angiographic images clearly demonstrate the pre-, peri-, and postoperative management of ischemic...
	Stem Cells and Revascularization Therapies (Biotechnology and Bioprocessing) by Hyunjoon Kong (Editor), Andrew J. Putnam (Editor), Lawrence B. Schook (Editor) In the last few decades, significant advancements in the biology and engineering of stem cells have enabled progress in their clinical application to revascularization therapies. Some strategies involve the mobilization of endogenous stem cell populations, and others employ cell transplantation. However, both techniques have benefited from multidisciplinary efforts to create biomaterials and other biomedical tools that can improve and control the fate of stem cells, and advance our understanding of them. Stem Cells and Revascularization Therapies focuses on the fundamentals and applied studies in stem cell biology, and provides perspectives associated with the development of revascularization strategies. To help readers understand the multidisciplinary issues associated with this topic,...
	Angiogenesis and Direct Myocardial Revascularization (Contemporary Cardiology) by Roger J. Laham (Editor), Donald S. Baim (Editor) An interdisciplinary panel of pioneers and opinion leaders review the basic, preclinical, clinical, and developmental pathways to new treatment strategies, such as therapeutic angiogenesis and myogenesis. The authors take advantage of new biological understanding, novel therapeutic targets, multiple available and well-studied therapeutic strategies, and the necessary imaging techniques to measure outcomes. Their in-depth discussions cover the identification of new therapeutic targets and pathways, the investigation of transcriptional factors, master switch molecules, cell-based approaches, chemokines, a better understanding of the effects of aging, endothelial dysfunction, and hypercholesterolemia in response to angiogenic stimuli. Highlights include examination of drug delivery problems,...
	Coronary Artery Disease: New Approaches without Traditional Revascularization by Gregory W. Barsness (Editor), David R. Holmes (Editor) A book directed towards individuals with an interest in the clinical treatment of patients with unrevascularizable angina. It explores the treatment options in the setting of a sound scientific background and provides guidance and predictions for future directions in this rapidly developing field. It is the only textbook of its kind and fulfils an unmet need for practicing internal medicine, family practice and cardiovascular clinicians. It also provides a reliable reference for clinical and basic researchers interested in this topic.
	Myocardial Revascularization: Novel Percutaneous Approaches by George S. Abela (Editor) The percutaneous method of transluminal myocardial revascularization has roused enthusiasm in the field of cardiology because it is minimally invasive and relatively inexpensive. In his progressive new book, George Abela, a widely recognized pioneer in cardiology and lasers, has brought together the expertise of international leaders on the subject in this premier reference, Myocardial Revascularization: Novel Percutaneous Approaches. This resource provides interventional cardiologists, technical personnel and nurses in cardiac catheterization labs with the most current scholarly and clinical information available, including: * A historical overview of myocardial revascularization (including the Vineberg procedure and the more recent TMR/PMR procedures) * Biological responses and...
	Acute Revascularization of the Infarcted Heart (A Society of Cardiovascular Anesthesiologists Monograph) by J. G. Reves (Editor)
	Myocardial Revascularization: Medical and Surgical Advances in Coronary Disease by D.T. Mason (Author), John J. Collins (Author)